Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.46 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KRAS | P01116 | 3/20 | 0.34 |
| ▸ | POLA1 | P09884 | 1/20 | 0.34 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20462522 | 1.00 | KDM4E (0.50) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL20462507 | 1.00 | KDM4E (0.50) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL20462537 | 1.00 | KDM4E (0.50) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL20462521 | 1.00 | KDM4E (0.50) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL24513564 | 0.90 | KDM4E (0.52) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL24517731 | 0.87 | KDM4E (0.45) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL30177246 | 0.87 | KDM4E (0.45) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL24513584 | 0.82 | KDM4E (0.41) | KDM4ETAS1R3TAS1R1IMPDH2POLB | |
| SCHEMBL20462534 | 0.82 | KDM4E (0.42) | KDM4ETAS1R3TAS1R1POLBALDH1A1 | |
| SCHEMBL20462536 | 0.82 | KDM4E (0.42) | KDM4ETAS1R3TAS1R1POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180222932-A1 | CHIRAL REAGENTS FOR PREPARATION OF HOMOGENEOUS OLIGOMERS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222932-A1 | CHIRAL REAGENTS FOR PREPARATION OF HOMOGENEOUS OLIGOMERS | RNGTT, MPHOSPH6, PMM2 | KDM4E 4529/4885TAS1R3 4503/4885TAS1R1 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.